West Oak Capital’s Medpace MEDP Stock Holding History

West Oak Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-225	Closed	-$43K	–	375
2021 Q3	$43K	Buy	+225	New	+$41K	0.02%	195

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

West Oak Capital's MEDP Position: Q4 2021 in Review

West Oak Capital sold out of Medpace (MEDP) in Q4 2021, closing a stake of 225 shares — an estimated $43K sold.

West Oak Capital first reported a position in MEDP in Q3 2021 and held it in 1 quarter. The position peaked at $43K in Q3 2021. 386 funds tracked by Wall St. Rank hold MEDP as of Q4 2021.

West Oak Capital reported no remaining Medpace position as of Q4 2021 after selling out during the quarter.
West Oak Capital sold 225 Medpace shares in Q4 2021, an estimated $43K.
West Oak Capital first reported a position in Medpace in Q3 2021 and held it in 1 quarter.
West Oak Capital's Medpace position peaked at $43K in Q3 2021.
386 funds tracked by Wall St. Rank held Medpace as of Q4 2021.

Based on West Oak Capital's 13F filing for Q4 2021, filed 12 Jan 2022.